Anti-HSV1/HHV-1 ICP0 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22318; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-HSV1/HHV-1 ICP0 Polyclonal Antibody: A Powerful Tool for Studying Herpes Simplex Virus 1 and Human Herpesvirus 1
The Anti-HSV1/HHV-1 ICP0 Polyclonal Antibody is a highly specific and reliable tool for the study of Herpes Simplex Virus 1 (HSV1) and Human Herpesvirus 1 (HHV-1). This antibody targets the infected cell protein 0 (ICP0) of both viruses, making it an essential tool for researchers studying the biology, pathogenesis, and potential treatments for these common and persistent viruses.
ICP0 is a key regulatory protein that plays a crucial role in the replication and pathogenesis of HSV1 and HHV-1. It is involved in viral gene expression, immune evasion, and the establishment of latency in host cells. The Anti-HSV1/HHV-1 ICP0 Polyclonal Antibody specifically binds to ICP0, enabling researchers to study its function and interactions with other viral and host proteins.
The Anti-HSV1/HHV-1 ICP0 Polyclonal Antibody is a valuable tool for a wide range of applications in virology research. It can be used for Western blotting, immunofluorescence, and immunohistochemistry to detect and visualize ICP0 in infected cells. This antibody is also suitable for immunoprecipitation and co-immunoprecipitation experiments to identify ICP0 binding partners and study its role in viral replication and pathogenesis.
The Anti-HSV1/HHV-1 ICP0 Polyclonal Antibody has been used in numerous studies to investigate the mechanisms of HSV1 and HHV-1 infection and to identify potential targets for antiviral therapies. For example, researchers have used this antibody to study the role of ICP0 in viral gene expression and immune evasion, as well as its interactions with host proteins such as p53 and HDAC1. This antibody has also been used to evaluate the efficacy of potential antiviral compounds against HSV1 and HHV-1.
In addition, the Anti-HSV1/HHV-1 ICP0 Polyclonal Antibody has been used in clinical research to detect and quantify ICP0 expression in patient samples. This allows for the monitoring of viral replication and the evaluation of potential treatments for HSV1 and HHV-1 infections.
Conclusion:
In summary, the Anti-HSV1/HHV-1 ICP0 Polyclonal Antibody is a highly specific and versatile tool for studying HSV1 and HHV-1. Its ability to target the key regulatory protein ICP0 makes it an essential component in virology research, with applications ranging from basic research to clinical studies. With this antibody, researchers can gain valuable insights into the biology and pathogenesis of these persistent viruses, ultimately leading to the development of effective treatments. Order now and enhance your research with the Anti-HSV1/HHV-1 ICP0 Polyclonal Antibody.
ProteoGenix catalogue number ARO-A22318. For research use only.
Target: E3 ubiquitin-protein ligase ICP0, EC:2.3.2.27, Alpha-0 protein, Immediate-early protein IE110, RING-type E3 ubiquitin transferase ICP0, Trans-acting transcriptional protein ICP0, VMW110, ICP0; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| E3 ubiquitin-protein ligase ICP0, EC |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
